Almanack Investment Partners LLC. Acquires New Stake in Intuitive Surgical, Inc. $ISRG

Key Points

• Almanack Investment Partners LLC has acquired a new stake in Intuitive Surgical, purchasing 1,313 shares valued at approximately $713,000 during the second quarter.
• In the last three months, company insiders sold a total of 45,224 shares worth $21.7 million, including significant sales by Director Amy L. Ladd and insider Gary S. Guthart.
• Intuitive Surgical reported better-than-expected earnings in its latest quarter, with $2.19 earnings per share, exceeding analysts' consensus estimates of $1.93.

Almanack Investment Partners LLC. acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 1,313 shares of the medical equipment provider's stock, valued at approximately $713,000.

A number of other large investors also recently bought and sold shares of ISRG. Brighton Jones LLC boosted its holdings in Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock valued at $1,916,000 after acquiring an additional 731 shares during the period. GAMMA Investing LLC boosted its holdings in Intuitive Surgical by 9.3% during the 1st quarter. GAMMA Investing LLC now owns 6,115 shares of the medical equipment provider's stock valued at $3,029,000 after acquiring an additional 518 shares during the period. Elevation Point Wealth Partners LLC boosted its holdings in Intuitive Surgical by 16.1% during the 1st quarter. Elevation Point Wealth Partners LLC now owns 562 shares of the medical equipment provider's stock valued at $278,000 after acquiring an additional 78 shares during the period. CVA Family Office LLC boosted its holdings in Intuitive Surgical by 6.4% during the 1st quarter. CVA Family Office LLC now owns 678 shares of the medical equipment provider's stock valued at $336,000 after acquiring an additional 41 shares during the period. Finally, Goldstone Financial Group LLC lifted its holdings in shares of Intuitive Surgical by 63.2% in the 1st quarter. Goldstone Financial Group LLC now owns 837 shares of the medical equipment provider's stock worth $415,000 after buying an additional 324 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Buying and Selling

In related news, Director Amy L. Ladd sold 335 shares of the company's stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $440.69, for a total transaction of $147,631.15. Following the transaction, the director directly owned 739 shares of the company's stock, valued at $325,669.91. This represents a 31.19% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Gary S. Guthart sold 29,360 shares of the company's stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares in the company, valued at $9,368,059.23. This represents a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock worth $21,716,492 in the last three months. 0.70% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several brokerages have weighed in on ISRG. Royal Bank Of Canada reiterated an "outperform" rating and issued a $615.00 target price on shares of Intuitive Surgical in a report on Tuesday, August 19th. Truist Financial upped their target price on Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft reiterated a "sell" rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Erste Group Bank reiterated a "hold" rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, Piper Sandler reiterated an "overweight" rating and issued a $595.00 target price (up from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Fourteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $589.43.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $429.59 on Monday. The stock has a market capitalization of $154.00 billion, a P/E ratio of 59.91, a price-to-earnings-growth ratio of 4.51 and a beta of 1.61. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The business has a fifty day moving average price of $458.68 and a 200 day moving average price of $497.84.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. The firm had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm's quarterly revenue was up 21.4% on a year-over-year basis. During the same period in the prior year, the business posted $1.78 EPS. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.